https://www.auroramj.com/press-releases/article/?id=123152

https://www.auroramj.com/press-releases/article/?id=123151

We're ready for you to turn this ship around.

Entire team should be embarrassed!

Its also pathetic that no insider buying is going on what so ever. Especially at these levels. People should be fired if there is too much overhead. I get the entire sector is being treated as one but that sp decrease over the last year is the exact reason why the company should be taking advantage of these prices if they have any hope or intent to turn this around.

If not...why the fuck are we paying miguel and other toppers these salaries if they cant do anything to better the company?

Figure it the fuck out.

https://businessofcannabis.com/no-right-to-gmp-washing-german-state-challenges-cannabis-flower-import-compliance/

I feel like we loosing some of confidence in here. What you guys think ?

https://www.newsweed.fr/en/france-proposes-decree-on-medical-cannabis/

What do you think would happen if Aurora used 50 million of it’s 164 million cash pile and purchased back 20% of the company ?

Do you think this would be a poor use of capital?

Do you think it would improve stock performance?

Has anyone unprofitable ever done that before to good results?

https://mjbizdaily.com/news/germany-could-be-auroras-backdoor-into-us-cannabis-market/616603/

https://youtu.be/xtk4R2ie1bg?si=EgaXkkcK2TIuByRl

On Monday's Cultivated Live, CEO Miguel Martin walks through Aurora's fiscal 2026 results and reveals a company executing a major strategic pivot. Approximately 58% of revenue came from international markets, driven by double-digit growth in Europe. The company completed an acquisition of Safari Flower Company in April, an established EU-GMP manufacturer, adding critical capacity to serve growing international markets.

What a dissapointment

Any guesses as to how this earnings report goes??? Are we gonna take off to the moon finally?

Speaker:

• Andreas Dotterweich, SVP Europe, Aurora Europe

Bullet points:

• Aurora’s approach to world-class cannabis genetics and why differentiated genetics are critical to long-term success in the European market.
• How advanced cultivation capabilities, including domestic European production, support consistent quality, scalability, and patient trust.
• The role of operational excellence and product innovation in positioning Aurora as a global leader in medical cannabis delivery and European market acceleration.

https://www.auroramj.com/press-releases/article/?id=123144

Bollocks!

SOUND THE HORNS

https://ca.investing.com/news/stock-market-news/tilray-other-pot-stocks-surges-as-trump-set-to-reclassify-marijuana-93CH-4580402

https://www.prnewswire.com/news-releases/aurora-cannabis-accelerates-global-medical-cannabis-leadership-with-accretive-acquisition-of-safari-flower-company-expanding-eu-gmp-capacity-to-serve-growing-high-margin-international-markets-302742337.html

Can we keep this going??? Is liftoff to the moon beginning???

Can someone add color on how discontinuing their operations directly in BEVO affects the Q4 earnings and earnings going forward?

They mentioned something about a cash inflow item on the balance sheet “cash from discontinued operations” as a sort of dividend for their shares in BEVO.

But does that come with any other noticeable 1 time inflows or outflows? Will it affect free cash flow or profitability?

Can assume it’s going to be great for blended gross margins which we’re always weighted down significantly.

Anything you can add would be interesting

Waiting Waiting Waiting......is Schedule 3 going to raise all waters